Rocket
Premium
Excel Add-In
International
Tools
Dashboard
Screener
Spinoffs
IPOs
Register
Alerts
Sign In
Overview
Financials
News + Filings
Key Docs
Ownership
Insiders
All
All (ex-4s)
10-K
10-Q
8-K
3,4,5
Proxy
Prospectus
Other
Tags
Filed Chapter 11
Appointed CFO
Quarterly results
Acq. announced
Director departure
CHEM RX CORP (CHRX)
Create:
Alert
All
|
News
|
Filings
Date Filed
Type
Description
02/22/2011
SC 13G/A
Form SC 13G/A - Statement of acquisition of beneficial ownership by individuals: [Amend]
08/13/2010
15-12G
Form 15-12G - Securities registration termination [Section 12(g)]
08/13/2010
15-12G
Form 15-12G - Securities registration termination [Section 12(g)]
08/13/2010
15-12G
Form 15-12G - Securities registration termination [Section 12(g)]
06/17/2010
8-K
Quarterly results
05/12/2010
8-K
Filed for Chapter 11
Docs:
"
CHEM RX FILES CHAPTER 11 TO FACILITATE REORGANIZATION
"
01/22/2010
SC 13G
Form SC 13G - Statement of acquisition of beneficial ownership by individuals
01/19/2010
8-K
Form 8-K - Current report
06/16/2009
8-K
Form 8-K - Current report
05/04/2009
8-K
Other Events, Financial Statements and Exhibits
Docs:
"
CHEM RX CORPORATION ENTERS SHORT-TERM FORBEARANCE AGREEMENTS WITH LENDERS LONG BEACH, N.Y., May 1, 2009 – Chem Rx Corporation , a leading provider of institutional pharmacy services, today announced that it has signed 45-day forbearance agreements with the requisite lenders under its two primary credit facilities. Per the agreements, lenders under the two credit facilities forebear from exercising certain rights and remedies until June 15, 2009. The Company intends to use the forbearance period to continue to negotiate appropriate waivers or amendments to its credit facilities with the lenders. As previously announced, the Company was in technical violation of three financial covenants under its credit facilities and has not paid its default interest. The covenants require the Company to m...
"
04/17/2009
SC 13D/A
Form SC 13D/A -- General statement of acquisition of beneficial ownership [amend]
04/01/2009
8-K
Form 8-K -- Current report
04/01/2009
NT 10-K
Form NT 10-K -- Notification of inability to timely file Form 10-K 405, 10-K, 10-KSB 405, 10-KSB, 10-KT, or 10-KT405
02/13/2009
SC 13G/A
MHR FUND MANAGEMENT LLC has filed a Schedule 13D for Chem Rx Corporation
02/12/2009
SC 13G/A
Form SC 13G/A -- Statement of acquisition of beneficial ownership by individuals [amend]
02/09/2009
SC 13G/A
Pine River Capital Management L.P. reports a 4.1% stake in Chem RX Corporation
01/28/2009
424B3
Form 424B3 - Prospectus [Rule 424(b)(3)]
01/21/2009
4
LOBELL J JAY (Director) has filed a Form 4 on CHEM RX CORP
01/21/2009
4
SELZER EVAN (Executive Vice President) has filed a Form 4 on CHEM RX CORP
01/21/2009
4
SIEGEL LESLIE (VP - OPS & TECHNOLOGY) has filed a Form 4 on CHEM RX CORP
01/21/2009
4
AGOGLIA PAULA (VP - OPS & CLIENT SERVICING) has filed a Form 4 on CHEM RX CORP
01/21/2009
4
KELLMAN DAVID J (Director) has filed a Form 4 on CHEM RX CORP
01/20/2009
4
JACOBS GARY MARK (CFO) has filed a Form 4 on CHEM RX CORP
01/20/2009
8-K
Form 8-K -- Current report
01/14/2009
4
SILVA STEVEN C (President and COO) has filed a Form 4 on CHEM RX CORP
01/14/2009
4
SILVA JERRY (Chairman and CEO) has filed a Form 4 on CHEM RX CORP
12/29/2008
8-K
Form 8-K -- Current report
11/25/2008
DEF 14A
Form DEF 14A - Other definitive proxy statements:
11/14/2008
10-Q
Quarterly Report for the period ended September 30, 2008
11/14/2008
8-K
Quarterly results
Docs:
"
Gary M. Jacobs Chief Financial Officer Chem Rx Corporation 516-889-8770 Stephanie Carrington The Ruth Group 646-536-7017
[email protected]
Chem Rx Corporation Reports Third Quarter 2008 Financial Results - Conference Call Scheduled for Friday, November 14, 2008 at 8:30 a.m. ET - Recent Highlights:
"
11/04/2008
8-K
Form 8-K -- Current report
09/24/2008
8-K
Form 8-K -- Current report
08/14/2008
10-Q
Quarterly Report for the period ended June 30, 2008
08/14/2008
8-K
Quarterly results
Docs:
"
Exhibit 99.1 Gary M. Jacobs Chief Financial Officer Chem Rx Corporation 516-889-8770 Stephanie Carrington / Jared Hoffman The Ruth Group 646-536-7017 / 7013
[email protected]
[email protected]
Chem Rx Corporation Reports Second Quarter 2008 Financial Results - Conference Call Scheduled Thursday, August 14, 2008 at 8:30 a.m. ET - Recent Highlights:
"
Next >>
Rocket Data Systems, Inc. © 2019 |
Contact Us
|
Data Disclaimer
|
Terms of Use
|
Privacy